| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1812890-23-5 | 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine | C13H21N5 |
| 1814936-54-3 | (SP-4-1)-[1,3-Bis[2,6-bis(1-propylbutyl)phenyl]-4,5-dichloro-1,3-dihydro-2H-imidazol-2-ylidene]dichloro(3-chloropyridine-$greek954$N)-Palladium | C48H72Cl5N3Pd |
| 1815580-54-1 | 5-Chloro-6-(hydroxymethyl)-2,4(1H,3H)-pyrimidinedione | C5H5ClN2O3 |
| 1815589-51-5 | 2-Fluoro-N-[(1S)-1-[[1-(1H-indazol-5-yl)-3-methyl-2,4-dioxo-1,3,8-triazaspiro[4.5]dec-8-yl]carbonyl]-2-methylpropyl]-5-(trifluoromethyl)benzamide | C28H28F4N6O4 |
| 1815608-51-5 | Para-Vortioxetine Impurity | C18H22N2S |
| 1815617-95-8 | L-Seryl-L-tyrosyl-L-seryl-L-methionyl-L-histidyl-L-phenylalanyl-L-arginyl-L-tryptophylglycyl-L-lysyl-L-prolyl-L-valylglycyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-prolyl-L-valyl-L-lysyl-L-valyl-L-tyrosyl-L-proline | C131H203N39O28S |
| 1816254-91-7 | n-Butyldi(tert-butyl)phosphonium tetrafluoroborate | C12H28BF4P |
| 1817735-82-2 | Etoricoxib Impurity 13 | C25H20ClN3O3S |
| 1818258-87-5 | Melphalan EP Impurity A Hydrochloride | C13H20N2O4 .HCl |
| 1818286-63-3 | (1R,3S)-5-((Z)-2-((7aR)-1-((2R,5R,E)-5,6-Dimethylhept-3-en-2-yl)-7a-methyl-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl)vinyl)-4-methylcyclohex-4-ene-1,3-diol | C28H44O2 |
| 1818294-29-9 | 4,7,10,13,16,19,22-Heptaoxapentacos-24-ynoic acid 1,1-dimethylethyl ester | C22H40O9 |
| 1818294-42-6 | 33-Amino-4,7,10,13,16,19,22,25,28,31-decaoxatritriacontanoic acid 1,1-dimethylethyl ester | C27H55NO12 |
| 1818294-43-7 | 30-Azido-4,7,10,13,16,19,22,25,28-nonaoxatriacontanoic acid 1,1-dimethylethyl ester | C25H49N3O11 |
| 1818294-44-8 | 30-amino-4,7,10,13,16,19,22,25,28-Nonaoxatriacontanoic acid 1,1-dimethylethyl ester | C25H51NO11 |
| 1818294-45-9 | alpha-(2-Azidoethyl)-omega-[3-(1,1-dimethylethoxy)-3-oxopropoxy]-poly(oxy-1,2-ethanediyl) | |
| 1818843-14-9 | tert-Butyl N-[(2R)-azetidin-2-ylmethyl]carbamate hydrochloride | C9H18N2O2.HCl |
| 1818847-23-2 | (3R,4S)-rel-3-Bromo-4-fluoro-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester | C9H15BrFNO2 |
| 1818847-67-4 | (3R,4R)-rel-3-Bromo-4-fluoro-1-pyrrolidinecarboxylic acid 1,1-dimethylethyl ester | C9H15BrFNO2 |
| 1818885-28-7 | ARV-825 | C46H47ClN8O9S |
| 1819334-66-1 | Posaconazole impurity 18 | C44H49F2N8O4+ |
| 1819363-80-8 | (2E)-1-(2-Hydroxyphenyl)-3-[(1R,4R)-5-(2-pyridinyl)-2,5-diazabicyclo[2.2.1]hept-2-yl]-2-propen-1-one | C19H19N3O2 |
| 1820576-22-4 | (1R,2R)-2-Methoxycyclobutanamine hydrochloride | C5H12ClNO |
| 1820579-78-9 | (3S,4R)-tert-Butyl 3-amino-4-hydroxypiperidine-1-carboxylate | C10H20N2O3 |
| 1820683-14-4 | 5-Pyrimidineacetic acid methyl ester | C7H8N2O2 |
| 1820685-30-0 | 2-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzamide | C18H23N5O3 |
| 1820812-16-5 | 1,5-Anhydro-2,4-dideoxy-2-[4-fluoro-1,3-dihydro-5-methyl-1-oxo-6-[[4-(1H-pyrazol-1-yl)phenyl]methyl]-2H-isoindol-2-yl]-L-threo-pentitol | C24H24FN3O3 |
| 1820817-64-8 | Methanesulfonato{[4-(N,N-dimethylamino)phenyl]di-t-butylphosphino}(2'-amino-1,1'-biphenyl-2-yl)palladium(II) | C29H41N2O3PPdS |
| 1821027-16-0 | Iopromide impurity 18 | C15H17I3N2O7 |
| 1821122-73-9 | Imatinib EP impurity D | C53H51N12O2+ |
| 1821122-74-0 | 1-Methyl-1,4-bis[[4-[[[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]amino]carbonyl]phenyl]methyl]piperazinium iodide (1:1) | C53H51N12O2.I |
| 1821235-69-1 | 1-Bromo-4-phenyldibenzofuran | C18H11BrO |
| 1821386-21-3 | (Z)-3-((2'-(n'-hydroxycarbamimidoyl)-[1,1'-biphenyl]-4-yl)methyl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxylic acid | C22H18N4O4 |
| 1821387-73-8 | CU-T12-9 | C17H13F3N4O2 |
| 1821389-11-0 | 3,5,6-Trimethyl-alpha,alpha-di-2-propen-1-yl-2-pyrazinemethanol | C14H20N2O |
| 1821422-51-8 | Rosuvastatin isomer-12 | C26H36FN3O6S |
| 1821428-35-6 | 8-[6-[3-(Dimethylamino)propoxy]-3-pyridinyl]-1,3-dihydro-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-2H-imidazo[4,5-c]quinolin-2-one | C26H31N5O3 |
| 1821496-27-8 | 1-[[(2S)-2-Hydroxy-3-(1-piperidinyl)propyl]amino]-4-[[(2S)-2-oxiranylmethyl]amino]-9,10-anthracenedione | C25H29N3O4 |
| 1821769-41-8 | (3S,4R)-N,4-Dimethyl-1-(phenylmethyl)-3-piperidinamine hydrochloride (1:2) | C14H22N2.2(HCl) |
| 1821799-48-7 | Tert-butyl (3R,4S)-4-amino-3-hydroxypiperidine-1-carboxylate | C10H20N2O3 |
| 1821838-06-5 | Ethyl (S)-2-amino-5,5,5-trifluoropentanoate | C7H12F3NO2 |
| 1821908-48-8 | (2S)-2-Amino-N-[[4-(3,5-dimethylphenoxy)-3-methylphenyl]methyl]propanamide | C19H24N2O2 |
| 1822310-41-7 | 2-(Dibenzo[b,d]furan-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C18H19BO3 |
| 1822310-63-3 | 2-(8-Bromodibenzofuran-1-yl)-4,6-diphenyl-1,3,5-triazine | C27H16BrN3O |
| 1822463-67-1 | Lacosamide EP Impurity B | C14H18N2O4 |
| 1822851-79-5 | 2-Fluoro-1,1-cyclopropanedimethanol | C5H9FO2 |
| 1823255-95-3 | 1-(4-Bromophenyl)-1H-imidazole-4-carboxylic acid methyl ester | C11H9BrN2O2 |
| 1823256-51-4 | 1-Tert-butyl 3-methyl 3-(trifluoromethyl)pyrrolidine-1,3-dicarboxylate | C12H18F3NO4 |
| 1823404-28-9 | Ribociclib Impurity 18 | C9H11BrClN3 |
| 1823420-32-1 | 3-Bromopyrazolo[1,5-a]pyrimidine-6-carboxylic acid methyl ester | C8H6BrN3O2 |
| 1823431-32-8 | 4,6-Dichloro-2-(propylsulfinyl)-5-pyrimidinamine | C7H9Cl2N3OS |